Emerging Veterinary Antimicrobial Susceptibility Testing Market Trends: Technological Advancements in Veterinary Antimicrobial Susceptibility Testing bioMérieux's VITEK MS PRIME Receives FDA Clearance Shaping the Future of the Industry

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Veterinary Antimicrobial Susceptibility Testing Market Size Growth Forecast: What to Expect by 2025?
In recent years, the market size of veterinary antimicrobial susceptibility testing has seen robust growth. The market is projected to expand from its size of $37.12 billion in 2024 to $39.63 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The considerable growth during the historical period can be credited to factors such as environmental considerations, demand in precision medicine, one health approach, growing consumer awareness, and the rise in companion animal healthcare.

How Will the Veterinary Antimicrobial Susceptibility Testing Market Size Evolve and Grow by 2029?
The market for veterinary antimicrobial susceptibility testing is anticipated to witness significant expansion in the upcoming years, reaching a value of $53.66 billion by 2029, with a compound annual growth rate (CAGR) of 7.9%. This growth, predicted for the forecast period, is attributed to factors like mitigation of antibiotic resistance, stipulated regulatory criteria, the impact of global health events, along with an increase in pet ownership. Innovation in solutions, regulatory focus, control of zoonotic diseases, and standards in the livestock industry constitute the major trends during this forecast period.

View the full report here:
https://www.thebusinessresearchcompany.com/report/veterinary-antimicrobial-susceptibility-testing-global-market-report

What Drivers Are Propelling the Growth of Veterinary Antimicrobial Susceptibility Testing Market Forward?
The increasing occurrence of diseases transmitted between animals and people, known as zoonotic diseases, is predicted to fuel the expansion of the veterinary antimicrobial susceptibility testing market. These diseases can be transferred from one animal species to another, and even from humans to animals, or vice versa. As the rate of zoonotic diseases rises, there will be a necessity to conduct tests and determine the most effective medication for animals. Veterinary antimicrobial susceptibility testing is useful in selecting the best treatment for bacterial infections in animals by examining the animal's treatment history, among other things. For example, an article published by a US government agency, the World Health Organization, in July 2022 reported a 64% increase in zoonotic cases in Africa. In addition, the incidence of zoonotic diseases is escalating globally, including in India. These newly emerging infections in humans make up 60% of cases, with 816 out of 1407 human pathogens being zoonotic. Hence, the upsurge in zoonotic diseases is propelling the expansion of the veterinary antimicrobial susceptibility testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8177&type=smp

Which Emerging Trends Are Transforming the Veterinary Antimicrobial Susceptibility Testing Market in 2025?
The prevalence of technological advancements is emerging as a primary trend in the veterinary antimicrobial susceptibility testing market. A primary focus for leading firms in the veterinary market is the innovation of new techniques to maintain their competitive edge. The use of sophisticated imaging methods and algorithms for quicker, dependable, and precise veterinary AST (antimicrobial susceptibility testing) has recently been observed in the market. For example, in March 2022, bioMérieux, a biotechnology firm based in France, obtained FDA 510(k) clearance for their VITEK MS PRIME, MALDI-TOF1 type mass spectrometry identification system. Upon receiving FDA 510(k) clearance, this system is now commercially available in countries that recognize CE-marking, as well as in the United States. It facilitates rapid and correct pathogen identification, leading to faster, more specific antimicrobial treatment.

What Are the Key Segments in the Veterinary Antimicrobial Susceptibility Testing Market?
The veterinary antimicrobial susceptibility testing market covered in this report is segmented -

1) By Product Type: Disks And Plates, Culture Media, Accessories And Consumables, Automated AST (Antimicrobial Susceptibility Test) Instruments
2) By Animal Type: Livestock Animals, Companion Animals
3) By End-Use: Veterinary Reference Lab, Veterinary Research Institutes, Other End-Users

Subsegments:
1) By Disks And Plates: Antibiotic Disks, Agar Plates
2) By Culture Media: Selective Culture Media, General Purpose Media
3) By Accessories And Consumables: Incubators, Sterilization Equipment, Pipettes And Reagents
4) By Automated AST (Antimicrobial Susceptibility Test) Instruments: Fully Automated Systems, Semi-Automated Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8177&type=smp

Who Are the Key Players Shaping the Veterinary Antimicrobial Susceptibility Testing Market's Competitive Landscape?
Major companies operating in the veterinary antimicrobial susceptibility testing market are BioMérieux SA, Becton, dic*kinson and Company, Bio-Rad Laboratories, Bruker Corporation, Condalab SA, FASTinov SA, Hardy Diagnostics Co., HiMedia Laboratories, Liofilchem Srl, Mast Group Ltd., Neogen Corporation, SSI Diagnostica A/S, Synbiosis, Thermo Fisher Scientific Inc., Accelerate Diagnostics Inc., Alifax S.r.l., Biogal Galed Labs Ltd., Creative Diagnostics, Danaher Corporation, Eurofins Scientific SE, IDEXX Laboratories Inc., Merck Co. & KGaA, Microbiologics Inc., QIAGEN N.V., R-Biopharm AG, T2 Biosystems Inc., Vetoquinol S.A., Virbac Inc., Zoetis Inc.

What Geographic Markets Are Powering Growth in the Veterinary Antimicrobial Susceptibility Testing Market?
North America was the largest region in the veterinary antimicrobial susceptibility testing market in 2024. The regions covered in the veterinary antimicrobial susceptibility testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8177

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Reach out to us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

The Business Research Company, with over 17,500+ reports across 27 industries and 60+ geographies, backed by 1,500,000 datasets and insights from industry leaders, offers comprehensive market intelligence through its flagship product, the Global Market Model (GMM), delivering updated forecasts for informed decision-making.

This release was published on openPR.